Phyllodes tumour
Exam relevance: in 1 of more than 150 board exam reports · rank 171
- Specialty
- Gynaecology · Breast
- Images
- Endoscopy & gross 1
- Exam relevance
- 1 of more than 150 reports · rank 171
- Last updated
- 10/2026 · Dr. Pascal Bafteh
Contents
Images (1)
Definition
- Rare biphasic fibroepithelial tumour of the breast with a morphological continuum from benign to malignant, accounting for 0.3–1% of primary breast tumours.
Classification
- The WHO distinguishes benign, borderline and malignant tumours by nuclear atypia, stromal cellularity, mitoses, tumour margin and stromal overgrowth; 60–75% are benign.
- Benign tumours have fewer than 5 mitoses per 10 HPF, borderline tumours 5–9 and malignant tumours 10 or more.
Occurrence & epidemiology
Epidemiology
- Mainly women aged 40 to 50 years are affected; benign forms tend to occur at a younger age than borderline and malignant tumours.
Clinical features
- Through rapid growth the tumour can bulge the breast, stretch the skin and ulcerate; dilated skin veins and nipple changes occur.
- Enlarged axillary lymph nodes are relatively common and usually reactive, whereas nodal metastases are very rare.
Histology
- Histology shows a hypercellular stroma with an increased intracanalicular growth pattern and leaf-like structures, lined by a double layer of epithelium, projecting into cystic spaces.
Diagnosis
- Mammography usually shows well-defined, dense masses; ultrasound shows a solid hypoechoic mass, usually with posterior acoustic enhancement and often increased vascularity on Doppler, cystic areas being more typical of malignant forms.
- Distinction from fibroadenoma is difficult, especially on core biopsy; imaging alone cannot reliably distinguish benign from malignant forms.
Treatment principles
- Treatment consists of complete excision with clear margins, as phyllodes tumours frequently recur after incomplete resection; according to current evidence, a wide safety margin beyond a clear margin does not reliably reduce the recurrence risk.
- Surgical staging of the axilla is usually unnecessary because lymphatic spread is rare.
- Radiotherapy may be considered for malignant tumours; because of the tendency to recur, regular clinical and ultrasound follow-up is arranged.
Specific treatment regimens with drugs and doses are covered in the GynFuchs app.
Keep learning in the app
Further reading (selection)
Cross-references
More topics: Breast
Keep learning
Keep learning with flashcards, exam questions and spot diagnoses in the GynFuchs app – free, in your browser or as an app.
Related pages: Triple-negative breast cancer · B3 lesions of the breast · Ductal carcinoma in situ (DCIS)
Note: Learning content from the GynFuchs app (flashcards, exam questions, image cases) for medical education – not a treatment recommendation and no substitute for diagnosis or treatment decisions in individual cases. Treatment and management are deliberately not covered on this page.
